Teva Pharmaceutical Industries Ltd $ 12.84 0.09 (0.71%)

Volume:
7,214,942
Avg Vol (1m):
12,987,262
Market Cap $:
14.05 Bil
Enterprise Value $:
39.77 Bil
P/E (TTM):
0.00
P/B:
1.06
Warning! GuruFocus has detected 3 Severe warning signs with TEVA. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for TEVA (Teva Pharmaceutical Industries) from 1990 to Jun 07 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Teva Pharmaceutical Industries stock (TEVA) PE ratio as of Jun 07 2020 is 0. More Details

Teva Pharmaceutical Industries PE Ratio (TTM) Chart

EMBED

Teva Pharmaceutical Industries PE Ratio (TTM) Historical Data

Total 1288
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Teva Pharmaceutical Industries PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-06-070.0 2020-04-060.0
2020-06-050.0 2020-04-030.0
2020-06-040.0 2020-04-020.0
2020-06-030.0 2020-04-010.0
2020-06-020.0 2020-03-310.0
2020-06-010.0 2020-03-300.0
2020-05-290.0 2020-03-270.0
2020-05-280.0 2020-03-260.0
2020-05-270.0 2020-03-250.0
2020-05-260.0 2020-03-240.0
2020-05-250.0 2020-03-230.0
2020-05-220.0 2020-03-200.0
2020-05-210.0 2020-03-190.0
2020-05-200.0 2020-03-180.0
2020-05-190.0 2020-03-170.0
2020-05-180.0 2020-03-160.0
2020-05-150.0 2020-03-130.0
2020-05-140.0 2020-03-120.0
2020-05-130.0 2020-03-110.0
2020-05-120.0 2020-03-100.0
2020-05-110.0 2020-03-090.0
2020-05-080.0 2020-03-060.0
2020-05-070.0 2020-03-050.0
2020-05-060.0 2020-03-040.0
2020-05-050.0 2020-03-030.0
2020-05-040.0 2020-03-020.0
2020-05-010.0 2020-02-280.0
2020-04-300.0 2020-02-270.0
2020-04-290.0 2020-02-260.0
2020-04-280.0 2020-02-250.0
2020-04-270.0 2020-02-240.0
2020-04-240.0 2020-02-210.0
2020-04-230.0 2020-02-200.0
2020-04-220.0 2020-02-190.0
2020-04-210.0 2020-02-180.0
2020-04-200.0 2020-02-170.0
2020-04-170.0 2020-02-140.0
2020-04-160.0 2020-02-130.0
2020-04-150.0 2020-02-120.0
2020-04-140.0 2020-02-110.0
2020-04-130.0 2020-02-100.0
2020-04-100.0 2020-02-070.0
2020-04-090.0 2020-02-060.0
2020-04-080.0 2020-02-050.0
2020-04-070.0 2020-02-040.0

Teva Pharmaceutical Industries PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Address 5 Basel Street, Petach Tikva, ISR, 4951033
Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.